Contractile response of canine gallbladder and sphincter of Oddi to substance P and related peptides in vitro.
Substance P (SP) is a neurotransmitter peptide that is widely distributed in the body. Since SP has been demonstrated in the gallbladder (GB) and bile ducts of dogs, it may have a role in biliary motility. The objective of this study was to examine the effect of SP on the GB and sphincter of Oddi (SOD) of dogs in vitro, to evaluate the structure-activity relationship of SP, and to compare the contractile effect of SP with that of cholecystokinin octapeptide (CCK-8) and acetylcholine (Ach). Isolated longitudinal strips of GB and SOD from dogs were suspended in oxygenated Krebs buffer and the isometric tension responses to various doses of CCK-8, Ach, SP, and SP homologs [SP-free acid (SPFA), Octa-SP (O-SP), physalaemin (PHY)] were measured. We found that all the SP homologs, other than SPFA, stimulated GB and SOD contractions in vitro in a dose-dependent manner. The potency of SP and its homologs on GB and SOD was SP greater than or equal to PHY greater than O-SP; SPFA was without effect. CCK-8 was significantly more effective than SP on GB contraction, but unlike SP, CCK had no effect on SOD. The maximum contraction achieved by Ach was 1.3 (SOD) to 2.3 (GB) times greater than that achieved by SP, but the ED50 of SP was approximately 100- to 200-fold lower than that of Ach. The contractile effect of SP was partially blocked by 10(-5) M atropine.(ABSTRACT TRUNCATED AT 250 WORDS)
Guo
Y S
YS
Department of Surgery, University of Texas Medical Branch, Galveston 77550.
Singh
P
P
Gomez
G
G
Rajaraman
S
S
Thompson
J C
JC
D000109:Acetylcholine / Q000494:pharmacology*; D014670:Ampulla of Vater / Q000187:drug effects*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004285:Dogs; D005704:Gallbladder / Q000187:drug effects* / Q000502:physiology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010446:Peptide Fragments / Q000494:pharmacology; D010803:Physalaemin / Q000494:pharmacology; D012844:Sincalide / Q000494:pharmacology*; D009803:Sphincter of Oddi / Q000187:drug effects* / Q000502:physiology; D013329:Structure-Activity Relationship; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology*
D010446:Peptide Fragments; D010803:Physalaemin; D013373:Substance P; C032682:substance P (4-11); D001285:Atropine; D012844:Sincalide; D000109:Acetylcholine